Bidil.com presents health information for the African-American population
Title
BiDil — Prescription Drug for African Americans with Heart Disease
Description
BiDil was approved by the FDA based the results from the African American Heart Failure Trial (A-HeFT). The drug, which combines isosorbide dinitrate and hydralazine hydrochloride, was proven to be an effective treatment for African Americans with heart failure, cardiovascular disease, and/or diabetes.
Logos
